文献速递神经肿瘤

低转化生长因子-β3表达预测脑膜瘤恶性程度

Low Transforming Growth Factor-β3 Expression Predicts Tumor Malignancy in Meningiomas.
PubMed 文献 · World Neurosurg · 2019-01-28

该研究分析38例冷冻脑膜瘤样本中TGF-β3的mRNA表达水平,发现WHO I级脑膜瘤平均表达2.55,高于WHO II级(1.50)和III级(0.21)(P=0.008);复发脑膜瘤平均表达0.71,低于原发脑膜瘤的2.55(P=0.008);单因素分析显示低TGF-β3表达与肿瘤复发和死亡相关。

要点

  • WHO I级脑膜瘤TGF-β3平均表达2.55,高于II级(1.50)和III级(0.21),P=0.008。
  • 有手术史脑膜瘤TGF-β3平均表达0.71,低于原发脑膜瘤的2.55,P=0.008。
  • 单因素分析中TGF-β3表达与肿瘤复发(P=0.038)和死亡(P=0.041)相关。

核心结论

  • TGF-β3表达水平随WHO级别升高而逐渐下降,复发脑膜瘤低于原发脑膜瘤。
  • 基于单因素分析,低TGF-β3表达可预测脑膜瘤肿瘤复发和死亡。

研究设计与样本

  • 研究分析38例冷冻脑膜瘤样本中TGF-β3的mRNA表达水平,并进行临床数据收集、随访、相关性分析和生存分析。

主要发现

  • WHO I级脑膜瘤TGF-β3平均表达2.55,高于WHO II级(平均1.50)和WHO III级(平均0.21),Kruskal-Wallis检验P=0.008。
  • 有手术史脑膜瘤TGF-β3平均表达0.71,低于原发脑膜瘤的平均2.55,Mann-Whitney U检验P=0.008。
  • 肿瘤复发的预后因素包括WHO级别(P=0.001)、手术史(P<0.001)、肿瘤体积(P=0.045)、术前Karnofsky体能状态(P=0.001)、瘤周脑水肿(P=0.039)、术后放疗(P=0.001)、切除程度(P=0.039)和TGF-β3表达(P=0.038)。
  • 死亡的预后因素包括WHO级别(P<0.001)、手术史(P<0.001)、术前Karnofsky体能状态(P=0.002)、瘤周脑水肿(P=0.006)、术后放疗(P=0.007)、骨侵犯(P=0.03)和TGF-β3表达(P=0.041)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We sought to clarify the expression characteristics and prognostic significance of transforming growth factor (TGF)-β3 in cranial meningiomas. METHODS: We analyzed the expression of TGF-β3 at the mRNA level in 38 frozen meningioma samples. Clinical data collection, follow-up, correlations, and survival analyses were performed. RESULTS: World Health Organization (WHO) grade I meningiomas showed an average expression level of 2.55, which was higher than that of WHO grade II (average of 1.50) and WHO grade III (average of 0.21) (Kruskal-Wallis test, P = 0.008). For meningiomas with a history of surgery, the mean TGF-β3 expression level was 0.71, much lower than that of primary meningiomas with a mean value of 2.55 (Mann-Whitney U-test, P = 0.008). According to the Kaplan-Meier analysis and univariate Cox analysis, WHO grade (P = 0.001), history of surgery (P < 0.001), tumor volume (P = 0.045), preoperative Karnofsky Performance Status (P = 0.001), peritumoral brain edema (P = 0.039), postoperative radiotherapy (P = 0.001), degree of resection (P = 0.039), and TGF-β3 expression (P = 0.038) were prognostic factors for tumor recurrence. In addition, WHO grade (P < 0.001), history of surgery (P < 0.001), preoperative Karnofsky Performance Status (P = 0.002), peritumoral brain edema (P = 0.006), postoperative radiotherapy (P = 0.007), bone invasion (P = 0.03), and TGF-β3 expression (P = 0.041) were prognostic factors for mortality. CONCLUSIONS: TGF-β3 expression levels gradually declined with the increase of WHO grade and were lower in recurrent meningiomas than in primary meningiomas. Besides, low TGF-β3 expression was found to predict tumor recurrence and mortality in meningiomas based on univariate analysis.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ma J, Li D, Chen Y, et al. Low Transforming Growth Factor-β3 Expression Predicts Tumor Malignancy in Meningiomas. World Neurosurg. 2019. PMID: 30703597. doi:10.1016/j.wneu.2019.01.077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。